-
Investing in Clinical Guidelines to Enhance Health Technology Assessments and Reimbursement Decisions
Mar 10, 2025, 14:00 PM -
Patient Journey Mapping for Common Illness Care Services at Community Pharmacies
Mar 10, 2025, 14:00 PM -
Effectiveness of Early Remdesivir Initiation in Patients with Immunocompromising Conditions Hospitalized with COVID-19 by Variant Era, Level of Immunocompromise, and Age
Mar 10, 2025, 14:00 PM -
Cost Effectiveness of Pembrolizumab in Combination with Chemotherapy for the Treatment of Patients with Locally Advanced or Metastatic HER2-Negative Gastric or Gastroesophageal Cancer in Mexico
Mar 10, 2025, 14:00 PM -
Unmet Need in CIDP Patients Treated With Immunoglobin: Results of a Multinational Real-World Survey
Mar 10, 2025, 14:00 PM -
Evaluating the Clinical Effectiveness of Portable Ultrasonic Scalpel Applied in Urology Surgery
Mar 10, 2025, 14:00 PM -
Real-World (rw) Early Clinical Endpoints for Patients with Resectable Non-Small Cell Lung Cancer (NSCLC): A Database Evaluation Study
Mar 10, 2025, 14:00 PM -
An Epidemiological Assessment of the Stroke Burden in Hungary Using Data From the Global Burden of Disease Study (1990–2021)
Mar 10, 2025, 14:00 PM -
Retrospective Databases in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research
Mar 10, 2025, 14:00 PM -
Real-World Study of High-Risk Non-Muscle Invasive Bladder Cancer From Three Public Institutions in Mexico: Clinical Profile and Staging Patterns
Mar 10, 2025, 14:00 PM -
Microbiology Testing and Oral Antibiotic Treatment Among CKD Patients With Urinary Tract Infections: Real-World Evidence From a US EMR Network
Mar 10, 2025, 14:00 PM -
Frequency of Gram-Negative Bacteria at the Military Medical Center in Guatemala
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Costs in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real World Data
Mar 10, 2025, 14:00 PM -
Cost per Response Analysis of Deucravacitinib and Biologic Treatments for Moderate to Severe Plaque Psoriasis From the Perspective of the Brazilian Private Healthcare System
Mar 10, 2025, 14:00 PM -
Market Access as Defined by Professionals with Market Access Backgrounds - Scoping Review
Mar 10, 2025, 14:00 PM -
The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management
Mar 10, 2025, 14:00 PM -
Hospital Budget Impact Model of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Initiating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (RAs) for Cardiometabolic Risk Reduction in a Medicare Population
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Venetoclax Combination Therapies for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Aged 75 Years or Older, or Who Have Comorbidities That Preclude Use of Intensive Induction Chemotherapy
Mar 10, 2025, 14:00 PM
